Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage?

Ann Hematol. 2015 Aug;94(8):1413-4. doi: 10.1007/s00277-015-2406-z. Epub 2015 Jun 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Aged
  • Benzimidazoles / therapeutic use*
  • Dabigatran
  • Decision Making*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Intracranial Hemorrhages / diagnosis*
  • Intracranial Hemorrhages / drug therapy*
  • Male
  • Thrombin Time / methods
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / therapeutic use

Substances

  • Benzimidazoles
  • Fibrinolytic Agents
  • beta-Alanine
  • Dabigatran